Raymond James Financial Services Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,493
| Closed | -$248K | – | 3052 |
|
|
2020
Q3 | $248K | Buy |
4,493
+146
| +3% | +$8.06K | ﹤0.01% | 2394 |
|
|
2020
Q2 | $274K | Sell |
4,347
-875
| -17% | -$55.2K | ﹤0.01% | 2282 |
|
|
2020
Q1 | $267K | Sell |
5,222
-400
| -7% | -$20.5K | ﹤0.01% | 1905 |
|
|
2019
Q4 | $447K | Sell |
5,622
-325
| -5% | -$25.8K | ﹤0.01% | 2056 |
|
|
2019
Q3 | $289K | Buy |
5,947
+510
| +9% | +$24.8K | ﹤0.01% | 2270 |
|
|
2019
Q2 | $286K | Sell |
5,437
-3,850
| -41% | -$203K | ﹤0.01% | 2298 |
|
|
2019
Q1 | $492K | Sell |
9,287
-1,238
| -12% | -$65.6K | ﹤0.01% | 1910 |
|
|
2018
Q4 | $432K | Buy |
10,525
+15
| +0.1% | +$616 | ﹤0.01% | 1763 |
|
|
2018
Q3 | $399K | Buy |
10,510
+4,010
| +62% | +$152K | ﹤0.01% | 2092 |
|
|
2018
Q2 | $294K | Sell |
6,500
-3,789
| -37% | -$171K | ﹤0.01% | 2244 |
|
|
2018
Q1 | $497K | Buy |
10,289
+2,564
| +33% | +$124K | ﹤0.01% | 1720 |
|
|
2017
Q4 | $304K | Buy |
7,725
+325
| +4% | +$12.8K | ﹤0.01% | 2008 |
|
|
2017
Q3 | $230K | Buy |
+7,400
| New | +$230K | ﹤0.01% | 2187 |
|
|
2017
Q2 | – | Sell |
-6,250
| Closed | -$230K | – | 2542 |
|
|
2017
Q1 | $230K | Buy |
+6,250
| New | +$230K | ﹤0.01% | 2054 |
|